MOROCCO – Moroccan Federation of Pharmaceuticals Industry and Innovation (FMIIP) has partnered with International Finance Corporation (IFC) to enhance the sector’s efficiency and productivity.

FMIIP is a non-profit professional association founded in 1985 aimed at strengthening the Moroccan health system as a whole and improving the access to innovative and generic medicines.

It is the leading association in the sector with a network of 29 major operators and brings together the main national players as well as multinationals with a drug manufacturing site in Morocco.

IFC, the largest global development institution focused exclusively on the private sector in developing countries, will assist FMIIP members in reducing their carbon and water footprints along with improving efficiencies in their production processes.

As part of the partnership, IFC will share knowledge on best international practices, organize awareness-raising events as well as deliver training and capacity building workshops.

The agreement will help boost productivity and ultimately increase the sector’s competitiveness as well as mitigate climate change by reducing water and energy waste.

Our partnership with IFC will help local manufacturers strengthen their production capacities and improve their environmental practices,” said FMIIP’s President, Mohamed El Bouhmadi

He highlighted that the collaboration would also help increase the production of medicines especially generic ones in Morocco and North African region.

The partnership comes at the right time when Morocco’s pharmaceuticals sector is scaling up efforts to meet the demand for drugs post-covid-19.

The project supported by the government of Netherlands will help Morocco meet its target of offering Universal Health Coverage by 2025.

Furthermore, IFC is stepping up its partnership with key pharma players in the region to create an enabling environment to boost medicine production in Africa

Our support to pharmaceutical producers in Morocco will help make the sector more productive and energy-efficient including putting manufacturers in a better position to attract investment,” outlined Manuel Reyes-Retana , IFC’s Acting Regional Director for North Africa.

The partnership with FMIIP is part of a larger IFC North Africa pharma project being implemented in Egypt, Morocco and Tunisia to make the pharmaceuticals sector more resource efficient.

IFC works in more than 100 countries providing capital, expertise and influence to create markets and opportunities in developing countries.

In fiscal year 2021, IFC committed a record US$31.5 billion to private companies and financial institutions in developing countries , leveraging the power of the private sector to end extreme poverty and boost shared prosperity as economies grapple with the impacts of the COVID-19 pandemic.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE